Harrow Health Stock Today

HROW Stock  USD 23.32  0.31  1.35%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Harrow Health is selling for under 23.32 as of the 18th of March 2025; that is 1.35 percent increase since the beginning of the trading day. The stock's lowest day price was 22.84. Harrow Health has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
28th of September 2007
Category
Healthcare
Classification
Health Care
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 35.61 M outstanding shares of which 2.73 M shares are currently shorted by private and institutional investors with about 8.15 trading days to cover. More on Harrow Health

Moving together with Harrow Stock

  0.93ME 23Andme HoldingPairCorr
  0.91VANI Vivani Medical Earnings Call This WeekPairCorr

Moving against Harrow Stock

  0.81DVAX Dynavax TechnologiesPairCorr
  0.77VALN Valneva SE ADR Earnings Call TodayPairCorr
  0.47VIGL Vigil NeurosciencePairCorr
  0.44DMAC DiaMedica TherapeuticsPairCorr
  0.42SRZNW Surrozen WarrantPairCorr
  0.33EQ EquilliumPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Harrow Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President DivisionJohn MBA
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.460.38
Fairly Up
Slightly volatile
Gross Profit Margin0.470.63
Way Down
Slightly volatile
Total Current Liabilities59.6 M56.7 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total232.3 M221.3 M
Sufficiently Up
Slightly volatile
Total Assets376.9 M359 M
Sufficiently Up
Slightly volatile
Total Current Assets168.4 M160.4 M
Sufficiently Up
Slightly volatile
Debt Levels
Harrow Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Harrow Health's financial leverage. It provides some insight into what part of Harrow Health's total assets is financed by creditors.
Liquidity
Harrow Health currently holds 190.5 M in liabilities. Harrow Health has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Harrow Health's use of debt, we should always consider it together with its cash and equity.

Net Income

(20.87 Million)
Harrow Health (HROW) is traded on NASDAQ Exchange in USA. It is located in 102 Woodmont Boulevard, Nashville, TN, United States, 37205 and employs 315 people. Harrow Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 819.49 M. Harrow Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 35.61 M outstanding shares of which 2.73 M shares are currently shorted by private and institutional investors with about 8.15 trading days to cover. Harrow Health currently holds about 51.7 M in cash with 3.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Check Harrow Health Probability Of Bankruptcy
Ownership Allocation
Harrow Health has a total of 35.61 Million outstanding shares. Over half of Harrow Health's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Harrow Ownership Details

Harrow Stock Institutional Holders

InstituionRecorded OnShares
First Turn Management Llc2024-12-31
304.9 K
Royce & Associates, Lp2024-12-31
292.1 K
Renaissance Technologies Corp2024-12-31
277.7 K
Charles Schwab Investment Management Inc2024-12-31
255.2 K
Gilder Gagnon Howe & Co Llc2024-12-31
205.8 K
Goldman Sachs Group Inc2024-12-31
204 K
Morgan Stanley - Brokerage Accounts2024-12-31
202.2 K
Neuberger Berman Group Llc2024-12-31
200.5 K
Voloridge Investment Management, Llc2024-12-31
188.6 K
Opaleye Management Inc2024-12-31
M
Blackrock Inc2024-12-31
2.5 M
View Harrow Health Diagnostics

Harrow Health Historical Income Statement

At this time, Harrow Health's Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 157.2 M in 2025, despite the fact that Income Before Tax is likely to grow to (20.3 M). View More Fundamentals

Harrow Stock Against Markets

Harrow Health Corporate Management

Robert DDSSpecial AdvisorProfile
Jamie WebbDirector RelationsProfile
PharmD ShojaeiChief OfficerProfile
David MoufarrgeVP TechnologyProfile
RPh MannebachHead PharmacovigilanceProfile
Brett BurrellVice ComplianceProfile
CFA CMACFO SecProfile

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.